← Back to headlines
BofA Raises Price Target on Teva Pharmaceutical (TEVA)
Bank of America has raised its price target for Teva Pharmaceutical (TEVA) stock to $42.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
